Rivka Riven Kreitman, PhD, Senior Partner, KRDable Consulting
Rivka has been with Teva for 22 years during which she has held a number or roles ranging from BD (sourcing of new projects), running pharmacological studies assessing the mechanism of action of Copaxone (a drug for Multiple Sclerosis), Project leadership, managing the North America IR&D function and the Global Clinical Operation, heading the Global Innovative Research and Development (IR&D), focusing mainly on CNS, Autoimmune and Oncology and Heading Global Strategic Marketing, Biologics, Women’s health, Immunology and Cell therapy.
In her current role, Rivka is responsible for leading the search for new products, scientific evaluation of all opportunities and managing the collaboration with partners on early stage assets and technologies.
Rivka earned her PhD at the Weizmann Institute of Science, Israel (Biochemistry) and postdoctoral work at Princeton University, NJ, US (Molecular Biology). Prior to joining Teva, she worked at Tel-Aviv University, Israel (Department of Physiology and Pharmacology, Sackler School of Medicine).
Rivka is a board member of TL Biopharmaceuticals, an Executive Board member of the Philadelphia-Israel Chamber of Commerce and co-chair of its science and technology committee.